Kane Biotech Inc. announced that it will be unveiling the new brand for its coactiv+ Antimicrobial Wound Gel product ("Wound Gel") at the Symposium on Advanced Wound Care Fall forum ("SAWC Fall"). Both Kane Biotech and its U.S. Wound Gel distribution partner, ProgenaCare Global, will host informational booth at SAWC Fall introducing the new brand and recruiting practitioners to participate in clinical evaluations using the Company's Wound Gel. Kane will also present a technology poster on Kane's Wound Gel which is a combination of Kane's patented coactiv+??

technology and PHMB, paired with a non-ionic Pluronic surfactant with thermo-gelling properties. The combination of these three components provides for a moist environment in an easy-to-use gel that is optimized for sensitive wounds. The conference will take place from November 2-5, 2023, in Las Vegas, Nevada and is intended to connect the entire wound care community fostering inclusivity, innovation and interdisciplinary collaboration.

During this conference, Kane Biotech will present along with other important voices in Biotech and Wound Care.